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Sir
The South African Journal of Clinical Nutrition is held in 
high esteem by health professionals. With the power and 
esteem of the journal comes the responsibility to ensure 
that all articles, including all advertising, comply with the 
highest ethical standards and science-based evidence. 
It was therefore surprising to find a full-page advert on 
the back page of the most recent edition, SAJCN Issue 
2017;30(3):1-60, for the Lorisian 150plus Food Intolerance 
Test.
IgG testing for food intolerances is beyond ‘controversial’ 
and in fact not backed by any reasonable level of scientific 
support. Although this advert does not mention food allergy 
per se, it alludes to the test’s benefits in asthma, sinusitis, 
rhinitis and eczema. The American Academy of Allergy, 
Asthma & Immunology, the European Academy of Allergy 
and Immunology, the Allergy Society of South Africa, and 
other allergy societies and organisations all have position 
statements against the claims being made for IgG testing and 
for claims that the test is useful in food intolerance. 
Complaints against the claims for the test (IgG testing) 
were laid with the South African Advertising Standards 
Authority and were upheld. Lorisian states that the 150plus 
was developed by one of the world’s leading laboratories 
specialising in food intolerance testing, and refers to data 
from the University of York. This data has not been peer 
reviewed or published in a peer reviewed journal. I suspect 
that the data emanates from York Laboratories, and not the 
University of York. York Laboratories that developed this 
test has had numerous UK Advertising Standards Authority 
rulings against the claims for this test, i.e., effectiveness in 
diagnosing food intolerances.
It is therefore my opinion that accepting an advertisement 
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The process error in due policy is regretted and an apology is offered; the advert will not appear again in any future editions of the 
SAJCN. The transdisciplinary monitoring and care of our Journal is much appreciated. Corrective measures have been taken to 
prevent recurrence.    
